Variability in caffeine metabolism
- PMID: 6687705
- DOI: 10.1038/clpt.1983.80
Variability in caffeine metabolism
Abstract
Urinary metabolites excreted after oral caffeine were quantified in a healthy sample (n = 68) from the Toronto population by HPLC analyses. The profile of metabolites, assessed by examining particular metabolite ratios, was found to differ widely among subjects. Ratios denoting cytochrome P-450-dependent activities were shown to be interethnically variable between oriental and Caucasian groups, whereas those indicative of xanthine oxidase activity exhibited neither significant interindividual variation nor an ethnic difference. It was also shown that a ratio providing an index of polymorphic N-acetyltransferase activity holds promise as a simple marker for acetylator status in man.
Similar articles
-
Determination of urinary metabolites of caffeine for the assessment of cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activity in humans.Ther Drug Monit. 1996 Jun;18(3):254-62. doi: 10.1097/00007691-199606000-00006. Ther Drug Monit. 1996. PMID: 8738764 Clinical Trial.
-
Caffeine metabolism in cystic fibrosis: enhanced xanthine oxidase activity.Clin Pharmacol Ther. 1994 Nov;56(5):521-9. doi: 10.1038/clpt.1994.173. Clin Pharmacol Ther. 1994. PMID: 7955816
-
Analysis of urinary caffeine metabolites to assess biotransformation enzyme activities by reversed-phase high-performance liquid chromatography.J Chromatogr B Biomed Sci Appl. 1998 May 8;709(1):27-34. doi: 10.1016/s0378-4347(98)00016-4. J Chromatogr B Biomed Sci Appl. 1998. PMID: 9653923
-
The use of caffeine as a metabolic probe for human drug metabolizing enzymes.Gen Pharmacol. 1996 Mar;27(2):245-9. doi: 10.1016/0306-3623(95)02014-4. Gen Pharmacol. 1996. PMID: 8919637 Review.
-
[Progress in the research of caffeine metabolism and its application in vivo].Sheng Li Ke Xue Jin Zhan. 2010 Aug;41(4):256-60. Sheng Li Ke Xue Jin Zhan. 2010. PMID: 21416940 Review. Chinese.
Cited by
-
Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.J Clin Invest. 1990 Mar;85(3):968-72. doi: 10.1172/JCI114527. J Clin Invest. 1990. PMID: 2312737 Free PMC article.
-
The effects of obesity and exercise on the pharmacokinetics of caffeine in lean and obese volunteers.Eur J Clin Pharmacol. 1987;31(5):595-600. doi: 10.1007/BF00606637. Eur J Clin Pharmacol. 1987. PMID: 3830245 Clinical Trial.
-
Thiopurine methyltransferase activity in a French population: h.p.l.c. assay conditions and effects of drugs and inhibitors.Br J Clin Pharmacol. 1994 Jul;38(1):1-8. doi: 10.1111/j.1365-2125.1994.tb04314.x. Br J Clin Pharmacol. 1994. PMID: 7946931 Free PMC article.
-
Caffeine as a metabolic probe: a comparison of the metabolic ratios used to assess CYP1A2 activity.Br J Clin Pharmacol. 1995 Jan;39(1):65-9. doi: 10.1111/j.1365-2125.1995.tb04411.x. Br J Clin Pharmacol. 1995. PMID: 7756101 Free PMC article.
-
Effect of allopurinol on caffeine disposition in man.Br J Clin Pharmacol. 1986 Apr;21(4):454-8. doi: 10.1111/j.1365-2125.1986.tb05222.x. Br J Clin Pharmacol. 1986. PMID: 3754760 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical